McCourt Marion bought REGN
December 5, 2025 · Form 4 insider transaction
McCourt Marion bought 12,210 shares of Regeneron Pharmaceuticals, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 4 days after the transaction.
Direction
Acquired (buy-side)
Shares
12,210
Price
$0.00
Total value
N/A
InsiderMcCourt Marion
Role—
SecurityNon-Qualified Stock Option (right to buy)
Transaction codeA: Grant or award
Transaction dateDecember 5, 2025
Filing dateDecember 9, 2025
Shares owned after12,210
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
The stock option award vests in four equal annual installments, commencing one year after the date of grant.